Home › Companies › Capricor Therapeutics, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Capricor Therapeutics, Inc.’s Form 8-K, filed June 8, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of June 4, 2026: 11 items on Capricor Therapeutics, Inc.’s Form 8-K, filed June 8, 2026: 2 approved · 1 not approved · 8 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025 2025-2026
Explore Capricor Therapeutics, Inc. in the interactive database Compare manager voting policies
These tallies are Capricor Therapeutics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 8, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Frank Litvack, M.D. | 21,114,485 | -- | -- | 9,678,907 | 13,030,489 | 69% | Not verified | — |
| Elect Director: Linda Marbán, Ph.D. | 25,482,880 | -- | -- | 5,310,512 | 13,030,489 | 83% | Not verified | — |
| Elect Director: David B. Musket | 24,952,805 | -- | -- | 5,840,587 | 13,030,489 | 81% | Not verified | — |
| Elect Director: George W. Dunbar, Jr. | 24,998,101 | -- | -- | 5,795,291 | 13,030,489 | 81% | Not verified | — |
| Elect Director: Karimah Es Sabar | 24,428,575 | -- | -- | 6,364,817 | 13,030,489 | 79% | Not verified | — |
| Elect Director: Paul Auwaerter, M.D. | 25,110,352 | -- | -- | 5,683,040 | 13,030,489 | 82% | Not verified | — |
| Elect Director: Philip Gotwals, Ph.D. | 25,480,357 | -- | -- | 5,313,035 | 13,030,489 | 83% | Not verified | — |
| Elect Director: Michael Kelliher | 25,378,932 | -- | -- | 5,414,460 | 13,030,489 | 82% | Not verified | — |
| 2. The ratification of the appointment by the Audit Committee of the Company's Board of Directors of Rose, Snyder & Jacobs LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2026 | 43,057,620 | 562,751 | 203,510 | -- | -- | 99% | Approved | — |
| 3. To approve, by non-binding advisory vote, the resolution approving named executive officer compensation | 24,336,434 | 6,244,316 | 212,642 | -- | 13,030,489 | 80% | Approved | — |
| 5. To approve an amendment to the Certificate of Incorporation regarding officer exculpation | 23,472,207 | 6,433,198 | 887,987 | -- | 13,030,489 | 78% | Not approved A stricter vote than a majority of the votes cast may have applied to this item; the filing does not state it. | — |
Source: Capricor Therapeutics, Inc., Form 8-K, filed with the SEC on June 8, 2026 — read the filing on EDGAR.
Each item below shows how the 194 asset managers that disclosed a Capricor Therapeutics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Capricor Therapeutics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
69% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Frank Litvack
Capricor Therapeutics, Inc.’s own tally for this item (“Elect Director: Frank Litvack, M.D.”): 21,114,485 for, 9,678,907 withheld, per its Form 8-K filed June 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 69% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 47 asset managers below reported 4,267,987 for, 2,019,784 withheld, 20 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,376,377 | 0 | 20 | 4,893 | For |
| Fidelity | 681,197 | 0 | 0 | 461,909 | Mixed |
| State Street | 1,043,090 | 0 | 0 | 2,892 | For |
| BlackRock | 0 | 0 | 0 | 785,553 | Withhold |
| TIAA | 0 | 0 | 0 | 212,760 | Withhold |
| Invesco | 0 | 0 | 0 | 154,185 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 125,988 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 70,821 | Withhold |
| Lincoln Financial | 37,649 | 0 | 0 | 0 | For |
| Equitable | 27,090 | 0 | 0 | 9,808 | Mixed |
| Northern Trust | 32,866 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 22,232 | Withhold |
| Global X | 0 | 0 | 0 | 20,297 | Withhold |
| RBB FUND, INC. | 19,388 | 0 | 0 | 0 | For |
| JPMorgan | 16,414 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 0 | 0 | 15,560 | Withhold |
| Pacific Life | 0 | 0 | 0 | 14,626 | Withhold |
| Voya | 0 | 0 | 0 | 14,288 | Withhold |
| Dunham Funds | 12,624 | 0 | 0 | 0 | For |
| Putnam | 0 | 0 | 0 | 12,340 | Withhold |
| John Hancock | 0 | 0 | 0 | 11,454 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 11,310 | Withhold |
| Goldman Sachs | 10,447 | 0 | 0 | 0 | For |
| MFS | 0 | 0 | 0 | 8,755 | Withhold |
| Bridge Builder Trust | 0 | 0 | 0 | 8,300 | Withhold |
Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.
Combines 3 wordings of this item as funds reported it.
81% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: David Musket
Capricor Therapeutics, Inc.’s own tally for this item (“Elect Director: David B. Musket”): 24,952,805 for, 5,840,587 withheld, per its Form 8-K filed June 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 81% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 47 asset managers below reported 6,266,100 for, 21,679 withheld, 12 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,376,385 | 0 | 12 | 4,893 | For |
| Fidelity | 1,143,106 | 0 | 0 | 0 | For |
| State Street | 1,044,562 | 0 | 0 | 1,420 | For |
| BlackRock | 785,553 | 0 | 0 | 0 | For |
| TIAA | 212,760 | 0 | 0 | 0 | For |
| Invesco | 154,185 | 0 | 0 | 0 | For |
| Charles Schwab | 125,988 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 70,821 | 0 | 0 | 0 | For |
| Lincoln Financial | 37,649 | 0 | 0 | 0 | For |
| Equitable | 36,898 | 0 | 0 | 0 | For |
| Northern Trust | 32,866 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,232 | 0 | 0 | 0 | For |
| Global X | 20,297 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 19,388 | 0 | 0 | 0 | For |
| JPMorgan | 16,414 | 0 | 0 | 0 | For |
| Brighthouse | 12,534 | 0 | 0 | 3,026 | Mixed |
| Pacific Life | 14,626 | 0 | 0 | 0 | For |
| Voya | 14,288 | 0 | 0 | 0 | For |
| Dunham Funds | 12,624 | 0 | 0 | 0 | For |
| Putnam | 0 | 0 | 0 | 12,340 | Withhold |
| John Hancock | 11,454 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 11,310 | 0 | 0 | 0 | For |
| Goldman Sachs | 10,447 | 0 | 0 | 0 | For |
| MFS | 8,755 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 8,300 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.
Combines 3 wordings of this item as funds reported it.
81% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: George Dunbar
Capricor Therapeutics, Inc.’s own tally for this item (“Elect Director: George W. Dunbar, Jr.”): 24,998,101 for, 5,795,291 withheld, per its Form 8-K filed June 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 81% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 47 asset managers below reported 6,267,675 for, 20,105 withheld, 12 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,377,959 | 0 | 12 | 3,318 | For |
| Fidelity | 1,143,106 | 0 | 0 | 0 | For |
| State Street | 1,044,562 | 0 | 0 | 1,420 | For |
| BlackRock | 785,553 | 0 | 0 | 0 | For |
| TIAA | 212,760 | 0 | 0 | 0 | For |
| Invesco | 154,185 | 0 | 0 | 0 | For |
| Charles Schwab | 125,988 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 70,821 | 0 | 0 | 0 | For |
| Lincoln Financial | 37,649 | 0 | 0 | 0 | For |
| Equitable | 36,898 | 0 | 0 | 0 | For |
| Northern Trust | 32,866 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,232 | 0 | 0 | 0 | For |
| Global X | 20,297 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 19,388 | 0 | 0 | 0 | For |
| JPMorgan | 16,414 | 0 | 0 | 0 | For |
| Brighthouse | 12,534 | 0 | 0 | 3,026 | Mixed |
| Pacific Life | 14,626 | 0 | 0 | 0 | For |
| Voya | 14,288 | 0 | 0 | 0 | For |
| Dunham Funds | 12,624 | 0 | 0 | 0 | For |
| Putnam | 0 | 0 | 0 | 12,340 | Withhold |
| John Hancock | 11,454 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 11,310 | 0 | 0 | 0 | For |
| Goldman Sachs | 10,447 | 0 | 0 | 0 | For |
| MFS | 8,755 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 8,300 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.
Combines 3 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Karimah Es Sabar
Capricor Therapeutics, Inc.’s own tally for this item (“Elect Director: Karimah Es Sabar”): 24,428,575 for, 6,364,817 withheld, per its Form 8-K filed June 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 47 asset managers below reported 6,081,717 for, 206,061 withheld, 13 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,379,702 | 0 | 13 | 1,574 | For |
| Fidelity | 1,143,106 | 0 | 0 | 0 | For |
| State Street | 1,045,982 | 0 | 0 | 0 | For |
| BlackRock | 785,553 | 0 | 0 | 0 | For |
| TIAA | 212,760 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 154,185 | Withhold |
| Charles Schwab | 125,988 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 70,821 | 0 | 0 | 0 | For |
| Lincoln Financial | 37,649 | 0 | 0 | 0 | For |
| Equitable | 36,898 | 0 | 0 | 0 | For |
| Northern Trust | 32,866 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,232 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 20,297 | Withhold |
| RBB FUND, INC. | 19,388 | 0 | 0 | 0 | For |
| JPMorgan | 16,414 | 0 | 0 | 0 | For |
| Brighthouse | 12,534 | 0 | 0 | 3,026 | Mixed |
| Pacific Life | 14,626 | 0 | 0 | 0 | For |
| Voya | 14,288 | 0 | 0 | 0 | For |
| Dunham Funds | 12,624 | 0 | 0 | 0 | For |
| Putnam | 0 | 0 | 0 | 12,340 | Withhold |
| John Hancock | 11,454 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 11,310 | 0 | 0 | 0 | For |
| Goldman Sachs | 10,447 | 0 | 0 | 0 | For |
| MFS | 8,755 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 8,300 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.
Combines 3 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Paul Auwaerter
Capricor Therapeutics, Inc.’s own tally for this item (“Elect Director: Paul Auwaerter, M.D.”): 25,110,352 for, 5,683,040 withheld, per its Form 8-K filed June 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 82% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 47 asset managers below reported 6,268,214 for, 19,565 withheld, 12 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,381,277 | 0 | 12 | 0 | For |
| Fidelity | 1,143,106 | 0 | 0 | 0 | For |
| State Street | 1,045,982 | 0 | 0 | 0 | For |
| BlackRock | 785,553 | 0 | 0 | 0 | For |
| TIAA | 212,760 | 0 | 0 | 0 | For |
| Invesco | 154,185 | 0 | 0 | 0 | For |
| Charles Schwab | 125,988 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 70,821 | 0 | 0 | 0 | For |
| Lincoln Financial | 37,649 | 0 | 0 | 0 | For |
| Equitable | 36,898 | 0 | 0 | 0 | For |
| Northern Trust | 32,866 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,232 | 0 | 0 | 0 | For |
| Global X | 20,297 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 19,388 | 0 | 0 | 0 | For |
| JPMorgan | 16,414 | 0 | 0 | 0 | For |
| Brighthouse | 12,534 | 0 | 0 | 3,026 | Mixed |
| Pacific Life | 14,626 | 0 | 0 | 0 | For |
| Voya | 14,288 | 0 | 0 | 0 | For |
| Dunham Funds | 12,624 | 0 | 0 | 0 | For |
| Putnam | 0 | 0 | 0 | 12,340 | Withhold |
| John Hancock | 11,454 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 11,310 | 0 | 0 | 0 | For |
| Goldman Sachs | 10,447 | 0 | 0 | 0 | For |
| MFS | 8,755 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 8,300 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.
Combines 3 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Philip Gotwals
Capricor Therapeutics, Inc.’s own tally for this item (“Elect Director: Philip Gotwals, Ph.D.”): 25,480,357 for, 5,313,035 withheld, per its Form 8-K filed June 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 83% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 47 asset managers below reported 6,272,414 for, 15,366 withheld, 11 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,381,278 | 0 | 11 | 0 | For |
| Fidelity | 1,143,106 | 0 | 0 | 0 | For |
| State Street | 1,045,982 | 0 | 0 | 0 | For |
| BlackRock | 785,553 | 0 | 0 | 0 | For |
| TIAA | 212,760 | 0 | 0 | 0 | For |
| Invesco | 154,185 | 0 | 0 | 0 | For |
| Charles Schwab | 125,988 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 70,821 | 0 | 0 | 0 | For |
| Lincoln Financial | 37,649 | 0 | 0 | 0 | For |
| Equitable | 36,898 | 0 | 0 | 0 | For |
| Northern Trust | 32,866 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,232 | 0 | 0 | 0 | For |
| Global X | 20,297 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 19,388 | 0 | 0 | 0 | For |
| JPMorgan | 16,414 | 0 | 0 | 0 | For |
| Brighthouse | 12,534 | 0 | 0 | 3,026 | Mixed |
| Pacific Life | 14,626 | 0 | 0 | 0 | For |
| Voya | 14,288 | 0 | 0 | 0 | For |
| Dunham Funds | 12,624 | 0 | 0 | 0 | For |
| Putnam | 0 | 0 | 0 | 12,340 | Withhold |
| John Hancock | 11,454 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 11,310 | 0 | 0 | 0 | For |
| Goldman Sachs | 10,447 | 0 | 0 | 0 | For |
| MFS | 8,755 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 8,300 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.
Combines 3 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Michael Kelliher
Capricor Therapeutics, Inc.’s own tally for this item (“Elect Director: Michael Kelliher”): 25,378,932 for, 5,414,460 withheld, per its Form 8-K filed June 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 82% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 47 asset managers below reported 6,272,414 for, 15,366 withheld, 11 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,381,278 | 0 | 11 | 0 | For |
| Fidelity | 1,143,106 | 0 | 0 | 0 | For |
| State Street | 1,045,982 | 0 | 0 | 0 | For |
| BlackRock | 785,553 | 0 | 0 | 0 | For |
| TIAA | 212,760 | 0 | 0 | 0 | For |
| Invesco | 154,185 | 0 | 0 | 0 | For |
| Charles Schwab | 125,988 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 70,821 | 0 | 0 | 0 | For |
| Lincoln Financial | 37,649 | 0 | 0 | 0 | For |
| Equitable | 36,898 | 0 | 0 | 0 | For |
| Northern Trust | 32,866 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,232 | 0 | 0 | 0 | For |
| Global X | 20,297 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 19,388 | 0 | 0 | 0 | For |
| JPMorgan | 16,414 | 0 | 0 | 0 | For |
| Brighthouse | 12,534 | 0 | 0 | 3,026 | Mixed |
| Pacific Life | 14,626 | 0 | 0 | 0 | For |
| Voya | 14,288 | 0 | 0 | 0 | For |
| Dunham Funds | 12,624 | 0 | 0 | 0 | For |
| Putnam | 0 | 0 | 0 | 12,340 | Withhold |
| John Hancock | 11,454 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 11,310 | 0 | 0 | 0 | For |
| Goldman Sachs | 10,447 | 0 | 0 | 0 | For |
| MFS | 8,755 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 8,300 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.
Combines 5 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Linda Marban
Capricor Therapeutics, Inc.’s own tally for this item (“Elect Director: Linda Marbán, Ph.D.”): 25,482,880 for, 5,310,512 withheld, per its Form 8-K filed June 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 83% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 6,253,693 for, 20,105 withheld, 11 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,377,960 | 0 | 11 | 3,318 | For |
| Fidelity | 1,143,106 | 0 | 0 | 0 | For |
| State Street | 1,044,562 | 0 | 0 | 1,420 | For |
| BlackRock | 785,553 | 0 | 0 | 0 | For |
| TIAA | 212,760 | 0 | 0 | 0 | For |
| Invesco | 154,185 | 0 | 0 | 0 | For |
| Charles Schwab | 125,988 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 70,821 | 0 | 0 | 0 | For |
| Lincoln Financial | 37,649 | 0 | 0 | 0 | For |
| Equitable | 36,898 | 0 | 0 | 0 | For |
| Northern Trust | 32,866 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,232 | 0 | 0 | 0 | For |
| Global X | 20,297 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 19,388 | 0 | 0 | 0 | For |
| JPMorgan | 16,414 | 0 | 0 | 0 | For |
| Brighthouse | 12,534 | 0 | 0 | 3,026 | Mixed |
| Pacific Life | 14,626 | 0 | 0 | 0 | For |
| Voya | 14,288 | 0 | 0 | 0 | For |
| Putnam | 0 | 0 | 0 | 12,340 | Withhold |
| John Hancock | 11,454 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 11,310 | 0 | 0 | 0 | For |
| Goldman Sachs | 10,447 | 0 | 0 | 0 | For |
| MFS | 8,755 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 8,300 | 0 | 0 | 0 | For |
| Prudential/PGIM | 7,200 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.
78% Not approved · of votes cast
Description as filed by funds: APPROVAL OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION REGARDING OFFICER EXCULPATION
Capricor Therapeutics, Inc.’s own tally for this item (“5. To approve an amendment to the Certificate of Incorporation regarding officer exculpation”): 23,472,207 for, 6,433,198 against — failed, per its Form 8-K filed June 8, 2026 (Item 5.07). This item required more than a simple majority of votes cast — see the filing.
Reported outcome: Not approved, in the filing’s own words: “The Company's stockholders did not approve an amendment to the Certificate of Incorporation regarding officer exculpation.”
A stricter vote than a majority of the votes cast may have applied to this item; the filing does not state it.
Support: 78% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 47 asset managers below reported 6,214,894 for, 69,869 against, 3,028 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,379,700 | 1,587 | 2 | 0 | For |
| Fidelity | 1,143,106 | 0 | 0 | 0 | For |
| State Street | 1,045,648 | 334 | 0 | 0 | For |
| BlackRock | 785,553 | 0 | 0 | 0 | For |
| TIAA | 212,760 | 0 | 0 | 0 | For |
| Invesco | 154,185 | 0 | 0 | 0 | For |
| Charles Schwab | 125,988 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 70,821 | 0 | 0 | 0 | For |
| Lincoln Financial | 26,200 | 11,449 | 0 | 0 | Mixed |
| Equitable | 36,898 | 0 | 0 | 0 | For |
| Northern Trust | 32,866 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,232 | 0 | 0 | 0 | For |
| Global X | 0 | 20,297 | 0 | 0 | Against |
| RBB FUND, INC. | 19,388 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 16,414 | 0 | 0 | Against |
| Brighthouse | 12,534 | 0 | 3,026 | 0 | Mixed |
| Pacific Life | 14,626 | 0 | 0 | 0 | For |
| Voya | 14,288 | 0 | 0 | 0 | For |
| Dunham Funds | 12,624 | 0 | 0 | 0 | For |
| Putnam | 12,340 | 0 | 0 | 0 | For |
| John Hancock | 11,454 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 11,310 | 0 | 0 | 0 | For |
| Goldman Sachs | 10,447 | 0 | 0 | 0 | For |
| MFS | 0 | 8,755 | 0 | 0 | Against |
| Bridge Builder Trust | 8,300 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.
Combines 9 wordings of this item as funds reported it.
80% Approved · of votes cast
Description as filed by funds: APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS
Capricor Therapeutics, Inc.’s own tally for this item (“3. To approve, by non-binding advisory vote, the resolution approving named executive officer compensation”): 24,336,434 for, 6,244,316 against — passed, per its Form 8-K filed June 8, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The compensation of the Company's named executive officers was approved, on a non-binding advisory basis, as follows:”
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,381,276 | 13 | 0 | 0 | For |
| Fidelity | 1,143,106 | 0 | 0 | 0 | For |
| State Street | 1,045,564 | 418 | 0 | 0 | For |
| BlackRock | 785,553 | 0 | 0 | 0 | For |
| TIAA | 212,760 | 0 | 0 | 0 | For |
| Invesco | 0 | 154,185 | 0 | 0 | Against |
| Charles Schwab | 125,988 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 70,821 | 0 | 0 | 0 | For |
| Lincoln Financial | 37,649 | 0 | 0 | 0 | For |
| Equitable | 36,898 | 0 | 0 | 0 | For |
| Northern Trust | 32,866 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,232 | 0 | 0 | 0 | For |
| Global X | 20,297 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 19,388 | 0 | 0 | 0 | For |
| JPMorgan | 16,414 | 0 | 0 | 0 | For |
| Brighthouse | 12,534 | 0 | 3,026 | 0 | Mixed |
| Pacific Life | 14,626 | 0 | 0 | 0 | For |
| Voya | 14,288 | 0 | 0 | 0 | For |
| Dunham Funds | 12,624 | 0 | 0 | 0 | For |
| Putnam | 12,340 | 0 | 0 | 0 | For |
| John Hancock | 11,454 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 11,310 | 0 | 0 | 0 | For |
| Goldman Sachs | 10,447 | 0 | 0 | 0 | For |
| MFS | 8,755 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 8,300 | 0 | 0 | 0 | For |
Fund voting reports, all 47 managers: 6,126,584 for, 158,182 against, 3,026 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,146,034 | 0 | 0 | 0 | For |
| State Street | 1,914,249 | 10,500 | 0 | 0 | For |
| MONTANOVA CAPITAL, LLC | 1,760,405 | 0 | 0 | 0 | For |
| BlackRock | 1,512,515 | 4,005 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 1,507,844 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 1,280,439 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 839,941 | 0 | 0 | 0 | For |
| Fidelity | 466,065 | 0 | 0 | 0 | For |
| J. Goldman & Co LP | 460,022 | 0 | 0 | 0 | For |
| DG Capital Management, LLC | 379,954 | 0 | 0 | 0 | For |
| Northern Trust | 303,331 | 6,999 | 0 | 0 | For |
| Boxer Capital Management, LLC | 307,060 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 250,000 | 0 | 0 | 0 | For |
| Nuveen | 221,576 | 0 | 0 | 0 | For |
| Invesco | 0 | 167,570 | 0 | 0 | Against |
| Vanguard | 164,027 | 0 | 0 | 0 | For |
| MOODY ALDRICH PARTNERS LLC | 143,716 | 0 | 0 | 0 | For |
| Charles Schwab | 126,023 | 0 | 0 | 0 | For |
| Ally Bridge Group (NY) LLC | 106,563 | 0 | 0 | 0 | For |
| Wellington | 74,784 | 0 | 0 | 0 | For |
| Pier Capital, LLC | 69,683 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 68,491 | 0 | 0 | 0 | For |
| UBS | 0 | 64,695 | 0 | 0 | Against |
| OPPENHEIMER & CO INC | 63,430 | 0 | 0 | 0 | For |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 0 | 61,300 | 0 | 0 | Against |
Institutional-manager reports, all 165 managers: 14,864,009 for, 435,367 against, 72 abstained, 6 not voted, 7,784 1 year. Showing the 25 largest; see all in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.9% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: APPROVAL OF FREQUENCY OF FUTURE NON-BINDING ADVISORY VOTES ON NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 1 | 0 | Abstain |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
| RBB FUND, INC. | 19,388 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| Brighthouse | 9,742 | 0 | 3,026 | 0 | Mixed |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| Dunham Funds | 12,624 | 0 | 0 | 0 | For |
| Putnam | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| MFS | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 47 managers: 41,754 for, 3,027 abstained, 6,242,955 1 year, 54 unknown. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 0 | 0 | 0 | 0 | -- |
| MONTANOVA CAPITAL, LLC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| RA CAPITAL MANAGEMENT, L.P. | 0 | 0 | 0 | 0 | -- |
| Palo Alto Investors LP | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| J. Goldman & Co LP | 0 | 0 | 0 | 0 | -- |
| DG Capital Management, LLC | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Boxer Capital Management, LLC | 0 | 0 | 0 | 0 | -- |
| RTW INVESTMENTS, LP | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| MOODY ALDRICH PARTNERS LLC | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Ally Bridge Group (NY) LLC | 106,563 | 0 | 0 | 0 | For |
| Wellington | 0 | 0 | 0 | 0 | -- |
| Pier Capital, LLC | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| UBS | 0 | 0 | 0 | 0 | -- |
| OPPENHEIMER & CO INC | 0 | 0 | 0 | 0 | -- |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 156 managers: 187,918 for, 212 against, 12,965,365 1 year, 1,300 3 year. Showing the 25 largest; see all in the interactive database.
99% Approved · of votes cast
Description as filed by funds: RATIFICATION OF THE SELECTION OF ROSE, SNYDER & JACOBS LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2026
Capricor Therapeutics, Inc.’s own tally for this item (“2. The ratification of the appointment by the Audit Committee of the Company's Board of Directors of Rose, Snyder & Jacobs LLP as the Company's independent registered accounting firm for the fiscal year ending December 3”): 43,057,620 for, 562,751 against — passed, per its Form 8-K filed June 8, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The appointment by the Audit Committee of the Company's Board of Directors of Rose, Snyder & Jacobs LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified as follows:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 47 asset managers below reported 6,284,723 for, 43 against, 3,026 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,381,288 | 1 | 0 | 0 | For |
| Fidelity | 1,143,106 | 0 | 0 | 0 | For |
| State Street | 1,045,940 | 42 | 0 | 0 | For |
| BlackRock | 785,553 | 0 | 0 | 0 | For |
| TIAA | 212,760 | 0 | 0 | 0 | For |
| Invesco | 154,185 | 0 | 0 | 0 | For |
| Charles Schwab | 125,988 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 70,821 | 0 | 0 | 0 | For |
| Lincoln Financial | 37,649 | 0 | 0 | 0 | For |
| Equitable | 36,898 | 0 | 0 | 0 | For |
| Northern Trust | 32,866 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,232 | 0 | 0 | 0 | For |
| Global X | 20,297 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 19,388 | 0 | 0 | 0 | For |
| JPMorgan | 16,414 | 0 | 0 | 0 | For |
| Brighthouse | 12,534 | 0 | 3,026 | 0 | Mixed |
| Pacific Life | 14,626 | 0 | 0 | 0 | For |
| Voya | 14,288 | 0 | 0 | 0 | For |
| Dunham Funds | 12,624 | 0 | 0 | 0 | For |
| Putnam | 12,340 | 0 | 0 | 0 | For |
| John Hancock | 11,454 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 11,310 | 0 | 0 | 0 | For |
| Goldman Sachs | 10,447 | 0 | 0 | 0 | For |
| MFS | 8,755 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 8,300 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 57,664,673 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.13% |
| 2 | Fidelity | 1.98% |
| 3 | State Street | 1.81% |
| 4 | BlackRock | 1.36% |
| 5 | TIAA | 0.37% |
| 6 | Invesco | 0.27% |
| 7 | Charles Schwab | 0.22% |
| 8 | QUANTITATIVE MASTER SERIES LLC | 0.12% |
| 9 | Lincoln Financial | 0.07% |
| 10 | Equitable | 0.06% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | TANG CAPITAL MANAGEMENT LLC | 3.72% |
| 2 | State Street | 3.34% |
| 3 | MONTANOVA CAPITAL, LLC | 3.05% |
| 4 | BlackRock | 2.63% |
| 5 | RA CAPITAL MANAGEMENT, L.P. | 2.61% |
| 6 | Palo Alto Investors LP | 2.22% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.46% |
| 8 | Fidelity | 0.81% |
| 9 | J. Goldman & Co LP | 0.80% |
| 10 | DG Capital Management, LLC | 0.66% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Nippon Shinyaku Co., Ltd. | 12.30% | DEF14A |
| TANG CAPITAL MANAGEMENT, LLC | 7.11% | 13G |
| BlackRock | 5.93% | 13F |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5.93% | 13G |
| RA Capital Management, L.P. | 5.23% | 13G |
| Millennium Management LLC | 5.10% | 13G |
| Vanguard Group | 4.44% | 13F |
| State Street | 3.78% | 13F |
| Linda Marbán, Ph.D. | 3.18% | DEF14A |
| Citadel Advisors | 2.50% | 13F |
Percentages above are of 57,664,673 shares outstanding, as reported by Capricor Therapeutics, Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Capricor Therapeutics, Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At Capricor Therapeutics, Inc.'s shareholder meeting held June 4, 2026, in the 2025-2026 proxy season, 194 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,113 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS — Capricor Therapeutics, Inc.'s filing reports the proposal as approved, with 80% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Capricor Therapeutics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 8, 2026.
Capricor Therapeutics, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.